{"a":[{"_":"Fierce Pharma Asia—Roche’s $2.5B obesity deal; Akeso CEO’s defense; Lawmaker’s reflection on China","$":{"href":"/pharma/roche-25b-obesity-deal-akeso-ceo-defense-congressman-reflection-china","hreflang":"en"}}]}

ivonescimabPositive

AI Analysis

Summary

Roche announced a $2.5B obesity deal with an undisclosed partner, pursuing an alternative approach in the obesity market. Akeso's CEO defended the company's ivonescimab lung cancer program amid data concerns.

Importance:7/10

Sentiment:

0.50

obesityM&Alung cancerivonescimabChina biotech

Related Companies

$RHHBY $CHHE

Read the original article

Published by FiercePharma on August 27, 2026 3:36 PM

Read Original